Jan Jezek

Dr, CSO of Arecor

Press citations per month · linked articles

Oct 2026Nov 2026to date

press citation on 1 topic since 1 Oct 2026 · last quoted 1 Oct 2026

02 Quoted on · 1 of 29 topics

Diabetes1

Open the topic

Jan Jezek: key facts

Kind of voice: Clinician
Role: Dr, CSO of Arecor
Quoted on: Diabetes
Tracked press citations: 1
Most recently quoted: 1 Oct 2026

03 Profile

04 On the record · press

What Jan Jezek has said

By outlet · linked articles

drwf.org.uk1

Where Jan Jezek has been quoted

01Trial examines high dose insulin treatment for people living with type 2 diabetesdrwf.org.uk · 1 Oct 2026

Verbatim

“The publication of the AT278-104 study in Diabetes, Obesity and Metabolism provides important peer-reviewed validation of our work advancing next-generation insulin formulations for people with high-dose insulin requirements.”

Dr, CSO of Arecor · Diabetes · drwf.org.uk · 1 Oct 2026 · Read the article

Related media coverage

Recent UK press coverage of their topics, not necessarily citing them directly.

First UK patient treated with NICE approved TeplizumabUniversity of Birmingham
Branding update for insulin pensDiabetes Research & Wellness Foundation
DRWF Events: Register now for Diabetes: A Whole Life BlueprintDiabetes Research & Wellness Foundation

Doctors, nurses, allied health professionals and other registered clinicians quoted in a clinical capacity. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 10 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.